Many patients continue making progress after reviewing their treatment plan, improving nutrition, increasing protein intake, adding resistance training, or adjusting medication under provider guidance
Sakaeda T, Tamon A, Kadoyama K, Okuno Y
As exclusivity ends, generic and biosimilar competition is expected to intensify, potentially reducing market share and pricing flexibility for current manufacturers
These drugs arent just for celebrities anymoremore and more people are turning to the medication and others like it to help them lose weight
Saxenda (liraglutide) tends to cause more nausea than either, and Byetta (exenatide) has the weakest overall tolerability profile of the group
Theres no waiting period after your weekly injection that makes alcohol safer